• NY Sport Coaching Hub
NY Sport Coaching Hub

Tag: drug-resistant gonorrhea

New Antibiotic Gepotidacin Achieves Breakthrough Against Drug-Resistant Gonorrhea in Major Trial
New Antibiotic Gepotidacin Achieves Breakthrough Against Drug-Resistant Gonorrhea in Major Trial

Kieran Lockhart, May, 22 2025

Gepotidacin, a first-in-class oral antibiotic, has shown a 93% success rate against drug-resistant gonorrhea in a large phase 3 trial, rivalling existing treatments. Oral dosing could boost accessibility, while parallel discoveries target resistant strains. The WHO urges urgent action as resistant gonorrhea becomes harder to treat.

Categories:

Health

Tags:

gepotidacin drug-resistant gonorrhea antibiotic clinical trial

Recent post

  • EuroMillions Results: No Jackpot Winner for £210 Million Draw on June 6, 2025—Massive Roll-Over Ahead
  • EuroMillions Results: No Jackpot Winner for £210 Million Draw on June 6, 2025—Massive Roll-Over Ahead
  • Why is the Super Bowl so popular in America?
  • Why is the Super Bowl so popular in America?
  • Harrison Solomon: Love Island’s Bold New Bombshell with a Football Twist
  • Harrison Solomon: Love Island’s Bold New Bombshell with a Football Twist
  • Danielle Lloyd Speaks Out About Her Skin Cancer Diagnosis
  • Danielle Lloyd Speaks Out About Her Skin Cancer Diagnosis
  • Injury Crisis Puts West Ham in Tight Spot Ahead of Brighton Showdown
  • Injury Crisis Puts West Ham in Tight Spot Ahead of Brighton Showdown

Categories

  • Sports
  • Entertainment
  • World News
  • Politics
  • Football
  • Technology
  • Business
  • Music
  • Music News
  • Crime

Archives

  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • August 2023
  • July 2023
  • May 2023
  • April 2023

Tags

Premier League Manchester United football Trump Chelsea Barcelona transfer Real Madrid Pacers Arsenal IPL 2025 NBA Finals Club World Cup Manchester City Championship La Liga Rangers Liverpool Bayern Munich winning numbers

© 2025. All rights reserved.